AbbVie looks beyond Humira with $63 billion deal for Botox-maker Allergan EP News Bureau Jun 27, 2019 AbbVie has long been under pressure to diversify its portfolio and its shares have lost more than a third of their value since…
Dr Reddy’s to acquire Teva’s product portfolio for US Market Usha Sharma Jun 13, 2016 The portfolio being acquired is a mix of filed ANDAs pending approval and an approved ANDA. It also comprises complex generic…
Pfizer calls off $160-billion merger with Allergan Sanjiv Das Apr 6, 2016 The decision to call off the merger came after the US Treasury Department announced new rules to discourage mergers between US and…
